Synthesis and Evaluation of Novel Carbocyclic Oxetanocin A (COA-Cl) Derivatives as Potential Tube Formation Agents
-
- Sakakibara Norikazu
- Faculty of Pharmaceutical Sciences at Kagawa Campus, Tokushima Bunri University
-
- Igarashi Junsuke
- Department of Cardiovascular Physiology, Faculty of Medicine, Kagawa University
-
- Takata Maki
- Department of Pharmaco-Bio-Informatics, Faculty of Medicine, Kagawa University
-
- Demizu Yosuke
- Division of Organic Chemistry, National Institute of Health Sciences
-
- Misawa Takashi
- Division of Organic Chemistry, National Institute of Health Sciences
-
- Kurihara Masaaki
- Division of Organic Chemistry, National Institute of Health Sciences
-
- Konishi Ryoji
- Department of Pharmaco-Bio-Informatics, Faculty of Medicine, Kagawa University
-
- Kato Yoshihisa
- Faculty of Pharmaceutical Sciences at Kagawa Campus, Tokushima Bunri University
-
- Maruyama Tokumi
- Faculty of Pharmaceutical Sciences at Kagawa Campus, Tokushima Bunri University
-
- Tsukamoto Ikuko
- Department of Pharmaco-Bio-Informatics, Faculty of Medicine, Kagawa University
この論文をさがす
抄録
Six novel carbocyclic oxetanocin A analogs (2-chloro-C.OXT-A; COA-Cl) with various hydroxymethylated or spiro-conjugated cyclobutane rings at the N9-position of the 2-chloropurine moiety were synthesized and evaluated using human umbilical vein endothelial cells. All prepared compounds (2a–f) showed good to moderate activity with angiogenic potency. Among these compounds, 100 µM cis–trans-2′,3′-bis(hydroxymethyl)cyclobutyl derivative (2b), trans-3′-hydroxymethylcyclobutyl analog (2d), and 3′,3′-bis(hydroxymethyl)cyclobutyl derivative (2e) had greater angiogenic activity, with relative tube areas of 3.43±0.44, 3.32±0.53, and 3.59±0.83 (mean±standard deviation (S.D.)), respectively, which was comparable to COA-Cl (3.91±0.78). These data may be important for further development of this class of compounds as potential tube formation agents.
収録刊行物
-
- CHEMICAL & PHARMACEUTICAL BULLETIN
-
CHEMICAL & PHARMACEUTICAL BULLETIN 63 (9), 701-709, 2015
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204177214848
-
- NII論文ID
- 130005096030
-
- NII書誌ID
- AA00602100
-
- ISSN
- 13475223
- 00092363
-
- NDL書誌ID
- 026700022
-
- PubMed
- 26329863
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
- KAKEN
-
- 抄録ライセンスフラグ
- 使用不可